Clinical Oncology - Issue 3/2025

Editorial

163

Influencer trendů

Reviews

170

Present management of gastrointestinal stromal tumors

S. Batko

177

Cancer in the elderly in Slovakia

M. Ondrušová, S. Vándor Svidová, A. Blažová, D. Ondruš

185

Current complex treatment for cervical cancer

R. Soumarová, J. Havlík

Original Articles

192

Real-world PD-L1 testing, fi rst-line therapy for advanced NSCLC, and fi rst-line pembrolizumab monotherapy utilization and outcomes for metastatic NSCLC in the Czech Republic

M. L. Santorelli, M. Chrápavá, K. Hrabcová, G. Bencina, J. Blažek, M. Bratová, O. Fibigr, #, O. Fischer, L. Koubková, J. Krejčí, A. Ryška, P. Zemanová, T. Burke

201

Total mesometrial resection for the treatment of cervical cancer – an exploratory study of feasibility, safety and oncological outcomes in developing countries

P. Sorokin, S. Kulikova, A. Stepanyan, H. Davtyan, M. Kuryllo, R. Oliveira, B. Rezende

Case Reports

209

Successful treatment of sepsis caused by multidrug-resistant Pseudomonas aeruginosa using cefi derocol in an immunocompromised hematological cancer patient fol lowing allogeneic hematopoietic stem cell transplantation

M. Navrátil

213

Long-term treatment effi cacy in a rapid growth malignant undiff erentiated lung tumor

Y. Maezawa, Y. Sasatani, G. Ohara, S. Okauchi, H. Kawai, H. Satoh

Short Communication

218

Practical recommendations for the use of PARP inhibitors in the treatment of ovarian cancer

D. Cibula, R. Kocián

224

Extravasation (paravasation) of anticancer drugs – updated recommendations (2025) for standard care in the Czech Republic based on multidisciplinary cooperation

S. Vokurka, V. Maňásek, D. Navrátilová Hrabánková, P. Rozsívalová, J. Kletečka, S. Šípová, V. Pavlicová, P. Žák, Š. Kozáková, A. Vlasáková, D. Brojáčová, L. Turková, B. Víšek

233

Pemigatinib v léčbě FGFR2+ cholangiokarcinomu – zázraky se dějí

236

Aktuality z Národního ústavu pro výzkum rakoviny

Clinical Oncology

2025 Issue 3